Filing Details
- Accession Number:
- 0001181431-14-006845
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-13 18:55:22
- Reporting Period:
- 2014-02-11
- Filing Date:
- 2014-02-13
- Accepted Time:
- 2014-02-13 18:55:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1485003 | Eleven Biotherapeutics Inc. | EBIO | Pharmaceutical Preparations (2834) | 252025616 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222012 | Noubar Afeyan | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | Yes | No | No | No | |
| 1255927 | Jr M Edwin Kania | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No | |
| 1503559 | Flagship Ventures Fund Iv, L.p. | 1 Memorial Drive Cambridge MA 02142 | No | No | Yes | No | |
| 1508051 | Flagship Ventures Fund Iv General Partner Llc | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No | |
| 1508052 | Flagship Ventures Fund 2007, L.p. | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No | |
| 1508053 | Flagship Ventures 2007 General Partner Llc | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No | |
| 1590973 | Flagship Ventures Fund Iv-Rx, L.p. | 1 Memorial Drive, 7Th Floor Cambridge MA 02142 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-11 | 1,417,323 | $0.00 | 1,692,913 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 926,017 | $0.00 | 1,041,427 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 231,504 | $0.00 | 260,356 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 214,095 | $10.00 | 1,907,008 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 131,722 | $10.00 | 1,173,149 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 32,912 | $10.00 | 293,268 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2014-02-11 | 9,000,000 | $0.00 | 1,417,323 | $0.00 |
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2014-02-11 | 4,200,000 | $0.00 | 661,417 | $0.00 |
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2014-02-11 | 1,050,000 | $0.00 | 165,354 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-02-11 | 1,680,213 | $0.00 | 264,600 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-02-11 | 420,053 | $0.00 | 66,150 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Held by Flagship Ventures Fund 2007, L.P. ("Flagship 2007"). Flagship Ventures 2007 General Partner LLC ("Flagship 2007 LLC") is the general partner of Flagship 2007. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship 2007 LLC. Flagship 2007 LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship 2007. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Mr. Afeyan is a member of the Issuer's board of directors.
- Held by Flagship Ventures Fund IV, L.P. ("Flagship IV"). Flagship Ventures Fund IV General Partner LLC ("Flagship IV LLC") is the general partner of Flagship IV. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship IV LLC. Flagship IV LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship IV. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Mr. Afeyan is a member of the Issuer's board of directors.
- Held by Flagship Ventures Fund IV-Rx, L.P. ("Flagship IV-Rx"). Flagship IV LLC is the general partner of Flagship IV Rx. Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship IV LLC. Flagship IV LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship IV-Rx. Each of the filing persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Mr. Afeyan is a member of the Issuer's board of directors.
- Each share of Series A and Series B Convertible Preferred Stock converted into 1/6.35 of a share of Common Stock upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The preferred shares had no expiration date.
Billionaire Hedge Funds
